根据今天的CCTV新闻，6月13日新闻，中国科学院动物学研究所的Liu Guanghui研究小组和Kuzin研究小组，以及Xuanwu的首都医院驾驶员Xuanwu医院的研究小组 Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Anti-Ant i-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-ondi we examine the ability to transform and its effect.在灵长类动物模型中，多机器人衰老的减速中，为人类衰老干预提供了一种新的细胞疗法范例离子。 ▲SRC治疗有效地逆转主要猴子的骨质疏松症。对照组（左）和SRC（右）治疗组使用具有相当于60-70个健康人类的生理状况的较旧的Sytomorgus猴子作为实验模型进行了44周的SRC干预研究。他从报告中得知，多次静脉注射SRC不会引起不良事件，消除了移植细胞和肿瘤发生的风险，并确认了SRC在非人类灵长类动物模型中植入SRC的安全性和免疫力。此外，研究人员全面评估了SRC干预对灵长类动物衰老模型的影响。结果表明，SRC移植可以使用多个Organsos显着降低猴子的老化过程，并重建身体的体内平衡。这已被揭示为改善认知功能，改善了多核变性病变，减少了衰老细胞的积累D改善基因组稳定性。这项研究打破了“传统疗法对独特疾病”的局限性，使用旨在实现多个器官抗衰老的细胞策略，证明了“设计生活以打击衰老”的生存能力，并证明了人类SRC可以系统地减慢灵长类动物和个人物种之间的差异。同时，系统地验证了安全性和有效性